Compound ID | 964
Lek 157
Synonym(s): LK-157 | Lek-157 | Lek157
Class: Beta-lactamase inhibitor
| Agent Type: | Semisynthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Mechanism of action: | Class A and class C beta-lactamases inhibitor |
| Combined with other compounds: | Was tested with ceftazidime, cefotaxime, ceftriaxone, cefepime and cefpirome |
| Description: | Carbapenem-type |
| Institute where first reported: | Lek Pharmaceuticals, Slovenia |
| Year first mentioned: | 2007 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.